Eubel Brady & Suttman Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.6M | Buy |
291,165
+53,105
| +22% | +$4.84M | 3.36% | 9 |
|
|
2025
Q1 | $26.9M | Buy |
238,060
+4,604
| +2% | +$521K | 3.55% | 7 |
|
|
2024
Q4 | $24.7M | Buy |
233,456
+3,128
| +1% | +$330K | 3.25% | 8 |
|
|
2024
Q3 | $24.9M | Buy |
230,328
+953
| +0.4% | +$103K | 3.24% | 8 |
|
|
2024
Q2 | $24.9M | Buy |
229,375
+6,372
| +3% | +$692K | 3.6% | 8 |
|
|
2024
Q1 | $29.4M | Sell |
223,003
-1,357
| -0.6% | -$179K | 3.74% | 5 |
|
|
2023
Q4 | $27.3M | Buy |
224,360
+34,669
| +18% | +$4.22M | 3.62% | 6 |
|
|
2023
Q3 | $21.3M | Buy |
189,691
+10,806
| +6% | +$1.21M | 3.11% | 11 |
|
|
2023
Q2 | $26M | Buy |
178,885
+1,037
| +0.6% | +$151K | 3.59% | 3 |
|
|
2023
Q1 | $23M | Buy |
177,848
+2,811
| +2% | +$363K | 3.33% | 12 |
|
|
2022
Q4 | $22.3M | Buy |
175,037
+3,229
| +2% | +$412K | 3.59% | 7 |
|
|
2022
Q3 | $18M | Buy |
171,808
+7,160
| +4% | +$749K | 3.21% | 10 |
|
|
2022
Q2 | $17.3M | Buy |
164,648
+76,170
| +86% | +$8M | 3.46% | 11 |
|
|
2022
Q1 | $11.3M | Buy |
+88,478
| New | +$11.3M | 2.08% | 24 |
|
|
2021
Q3 | – | Sell |
-112
| Closed | -$17K | – | 359 |
|
|
2021
Q2 | $17K | Buy |
+112
| New | +$17K | ﹤0.01% | 481 |
|